CN¥ 5.83
Key Takeaways
Risk factor
Good trading liquidity
Data is available to registered users only
Data is available to registered users only
Profitability factor
Greatly overvalued vs peers
Data is available to registered users only
Data is available to registered users only
About
Hainan Haiyao Co., Ltd. engages in the research, development, production, and sale of pharmaceuticals and medical devices. Its products include cephalosporin series, gastrointestinal series, oncology series, cochlear implant series, active pharmaceutical ingredient (API) series, and intermediate series. The company was founded in 1965 and is headquartered in Haikou, China.
Company Valuation
From both historical and forecast perspectives, the stock is considerably overpriced compared to similar stocks.
Data is available to registered users only